{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:50:07Z","timestamp":1788871807626,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T00:00:00Z","timestamp":1293753600000},"content-version":"vor","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)"},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.11.062","type":"journal-article","created":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T04:08:32Z","timestamp":1262318912000},"page":"1528-1534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis"],"prefix":"10.1016","volume":"28","author":[{"given":"Alice M.","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamelia L.","family":"Bocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 C.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Camila C.O.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00facia H.","family":"Faccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlete A.M.","family":"Coelho-Castelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor\u00eancio","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lio L.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sueli S.","family":"Felipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.11.062_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CMR.6.2.89","article-title":"Paracoccidioidomycosis: an update","volume":"6","author":"Brummer","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2009.11.062_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/00362178585380481","article-title":"The ecology of Paracoccidioides brasiliensis: a puzzle still unsolved","volume":"23","author":"Restrepo","year":"1985","journal-title":"J Med Vet Mycol"},{"key":"10.1016\/j.vaccine.2009.11.062_bib3","first-page":"41","article-title":"Current knowledge on pathogens and immunodiagnosis of paracoccidioidomycosis","volume":"17","author":"de Camargo","year":"2000","journal-title":"Rev Iberoam Mycol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.062_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1590\/S0037-86822006000300017","article-title":"Guidelines in paracoccidioidomycosis","volume":"39","author":"Shikanai-Yasuda","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.vaccine.2009.11.062_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","article-title":"Amphotericin B","volume":"68","author":"Lemke","year":"2005","journal-title":"Appl Microbiol Biotechnol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.062_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.vaccine.2008.10.022","article-title":"DNAhsp65 vaccination induces protection in mice against Paracoccidioides brasiliensis infection","volume":"27","author":"Ribeiro","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.11.062_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.drudis.2006.04.016","article-title":"Heat shock proteins as vaccine adjuvants in infections and cancer","volume":"11","author":"Segal","year":"2006","journal-title":"Drug Discov Today"},{"issue":"8","key":"10.1016\/j.vaccine.2009.11.062_bib8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1586\/14760584.7.8.1185","article-title":"Heat-shock proteins as powerful weapons in vaccine development","volume":"7","author":"Bolhassani","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2009.11.062_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/088282402760312296","article-title":"Role for heat shock proteins in the immune response to measles virus infection","volume":"15","author":"Oglesbee","year":"2002","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2009.11.062_bib10","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.4049\/jimmunol.169.10.5818","article-title":"The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V\u03b28.1\/8.2+ T cells","volume":"169","author":"Scheckelhoff","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.11.062_bib11","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1128\/IAI.72.12.6945-6950.2004","article-title":"A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice","volume":"72","author":"Ferraz","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.062_bib12","first-page":"1","article-title":"Immunity of fungal infections","volume":"4","author":"Romani","year":"2004","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.062_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/107999000312766","article-title":"Resistance to Paracoccidioides brasiliensis infection is linked to a preferential Th1 immune response, whereas susceptibility is associated with absence of IFN-gamma production","volume":"20","author":"Kashino","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.vaccine.2009.11.062_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S0031182005009753","article-title":"Immunological and pathological responses in BALB\/c mice induced by genetic administration of Tc13 Tul antigen of Trypanosoma cruzi","volume":"132","author":"Garc\u00eda","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2009.11.062_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00436-005-0088-5","article-title":"Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection","volume":"98","author":"Coelho","year":"2006","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2009.11.062_bib16","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1016\/j.vaccine.2007.10.012","article-title":"Mucosal delivery of a transmission-blocking DNA vaccine encoding Giardia lamblia CWP2 by Salmonella typhimurium bactofection vehicle","volume":"25","author":"Abdul-Wahid","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.11.062_bib17","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.3748\/wjg.v13.i44.5911","article-title":"Targeting hepatitis B virus antigens to dendritic cells by heat shock protein to improve DNA vaccine potency","volume":"13","author":"Gu","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.062_bib18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.vaccine.2006.09.089","article-title":"Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene","volume":"25","author":"Zhang","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.062_bib19","first-page":"61","article-title":"Heat shock proteins in health and disease","volume":"6","author":"Fa\u0142kowska-Podstawka","year":"2003","journal-title":"Pol J Vet Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.062_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/gt.2008.179","article-title":"A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients","volume":"16","author":"Li","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2009.11.062_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.gt.3302418","article-title":"Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice","volume":"12","author":"Silva","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2009.11.062_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1479-0556-5-2","article-title":"Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs","volume":"5","author":"de Paula","year":"2007","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.vaccine.2009.11.062_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00437630","article-title":"In vivo and in vitro characteristics of six Paracoccidioides brasiliensis strains","volume":"92","author":"Kashino","year":"1985","journal-title":"Mycopathologia"},{"key":"10.1016\/j.vaccine.2009.11.062_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/13693780310001610074","article-title":"Viability of yeast form cells of Paracoccidioides brasiliensis after sonication","volume":"42","author":"Dias","year":"2004","journal-title":"Med Mycol"},{"key":"10.1016\/j.vaccine.2009.11.062_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/02681219280000331","article-title":"The source of the growth-promoting factor(s) affects the plating efficiency of Paracoccidioides brasiliensis","volume":"30","author":"Singer-Vermes","year":"1992","journal-title":"J Med Vet Mycol"},{"key":"10.1016\/j.vaccine.2009.11.062_bib26","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.4049\/jimmunol.161.6.3056","article-title":"Treatment of Paracoccidioides brasiliensis-infected mice with a nitric oxide inhibitor prevents the failure of cell-mediated immune response","volume":"161","author":"Bocca","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.11.062_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.6451927","article-title":"Nitrate synthesis in the germfree and conventional rat","volume":"212","author":"Green","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.11.062_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0006-291X(89)91067-X","article-title":"Enzymatic formation of nitrogen oxides from l-arginine in bovine brain cytosol","volume":"165","author":"Schmidt","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2009.11.062_bib29","first-page":"16","article-title":"Microbiology of systemic fungal infections","volume":"51","author":"Chakrabarti","year":"2005","journal-title":"J Postgrad Med"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.062_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/aem.53.3.615-617.1987","article-title":"Antifungal activity of ajoene derived from garlic","volume":"53","author":"Yoshida","year":"1987","journal-title":"Appl Environ Microbiol"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2009.11.062_bib31","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1099\/00221287-143-5-1583","article-title":"Inhibition of Paracoccidioides brasiliensis by ajoene is associated with blockade of phosphatidylcholine biosynthesis","volume":"143","author":"San-Blas","year":"1997","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.062_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/13693780701651681","article-title":"Experimental paracoccidioidomycosis: alternative therapy with ajoene, compound from Allium sativum, associated with sulfamethoxazole\/trimethoprim","volume":"46","author":"Thomaz","year":"2008","journal-title":"Med Mycol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.11.062_bib33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4269\/ajtmh.1996.55.496","article-title":"The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis","volume":"55","author":"Meira","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"12\u201313","key":"10.1016\/j.vaccine.2009.11.062_bib34","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.micinf.2008.07.027","article-title":"Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis","volume":"10","author":"Marques","year":"2008","journal-title":"Microbes Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.062_bib35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jac\/dkn539","article-title":"Amphotericin B in poly(lactic-co-glycolic acid) (PLGA) and dimercaptosuccinic acid (DMSA) nanoparticles against paracoccidioidomycosis","volume":"63","author":"Amaral","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.062_bib36","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2007.05.038","article-title":"A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia","volume":"106","author":"Roman","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.vaccine.2009.11.062_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1537","article-title":"Advances in combating fungal diseases: vaccines on the threshold","volume":"5","author":"Cutler","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2009.11.062_bib38","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/infdis\/171.6.1668","article-title":"Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis","volume":"171","author":"Matthews","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.11.062_bib39","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1128\/IAI.70.7.3759-3767.2002","article-title":"Cellular and molecular regulation of vaccination with heat shock protein 60 from Histoplasma capsulatum","volume":"70","author":"Deepe","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.11.062_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/02681218880000151","article-title":"Mononuclear cell subsets in patients with different clinical forms of paracoccidioidomycosis","volume":"26","author":"Mota","year":"1988","journal-title":"J Med Vet Mycol"},{"key":"10.1016\/j.vaccine.2009.11.062_bib41","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1086\/517481","article-title":"Increased serum concentration of IL-10 in patients with hepatosplenic candidiasis","volume":"178","author":"Rolides","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.11.062_bib42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1286-4579(03)00040-6","article-title":"Production of pro- and anti-inflammatory cytokines by monocytes from patients with paracoccidioidomycosis","volume":"5","author":"Per\u00e7coli","year":"2003","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2009.11.062_bib43","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1086\/318077","article-title":"Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis","volume":"183","author":"Rolides","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.11.062_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0036-46652000000200001","article-title":"Fibrotic sequelae in pulmonary paracoccidioidomycosis: histopathological aspects in BALB\/c mice infected with viable and non-viable Paracoccidioides brasiliensis propagules","volume":"42","author":"Cock","year":"2000","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"10.1016\/j.vaccine.2009.11.062_bib45","first-page":"1","article-title":"Deficiency of IL-12p40 subunit determines severe paracoccidioidomycosis in mice","volume":"12","author":"Livonesi","year":"2008","journal-title":"Med Mycol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.11.062_bib46","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1517\/14712598.8.9.1255","article-title":"Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis","volume":"8","author":"Souza","year":"2008","journal-title":"Expert Opin Biol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09018659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:16:49Z","timestamp":1759400209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09018659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09018659"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}